Nitric Oxide Increases Insulin Sensitivity in Skeletal Muscle by Improving Mitochondrial Function and Insulin Signaling.
10.4093/kdj.2009.33.3.198
- Author:
Woo Je LEE
1
;
Hyoun Sik KIM
;
Hye Sun PARK
;
Mi Ok KIM
;
Mina KIM
;
Ji Young YUN
;
Eun Hee KIM
;
Sang Ah LEE
;
Seung Hun LEE
;
Eun Hee KOH
;
Joong Yeol PARK
;
Ki Up LEE
Author Information
1. Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea. wjlee@amc.seoul.kr
- Publication Type:In Vitro ; Original Article
- Keywords:
Insulin resistance;
Mitochondria;
Muscles;
Nitric oxide;
Signal transduction
- MeSH:
Animals;
Organelle Biogenesis;
Blotting, Western;
Deoxyglucose;
DNA, Mitochondrial;
Glucose;
Glucose Clamp Technique;
Humans;
Insulin;
Insulin Resistance;
Mitochondria;
Muscle Cells;
Muscle, Skeletal;
Muscles;
Nitric Oxide;
Rats;
Real-Time Polymerase Chain Reaction;
Receptor, Insulin;
RNA, Messenger;
Signal Transduction;
Tissue Donors
- From:Korean Diabetes Journal
2009;33(3):198-205
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Accumulating evidence has suggested that nitric oxide (NO) is involved in the regulation of insulin sensitivity in skeletal muscle. Recent studies also suggested NO as an important molecule regulating mitochondrial biogenesis. This study examined the effect of the NO donor, 3-morpholinosydnonimine (SIN-1), on glucose metabolism in skeletal muscle and tested the hypothesis that NO's effect on glucose metabolism is mediated by its effect on mitochondrial function. METHODS: In Sprague-Dawley (SD) rats treated with SIN-1 for 4 weeks, insulin sensitivity was measured by a glucose clamp study. Triglyceride content and fatty acid oxidation were measured in the skeletal muscle. In addition, mitochondrial DNA content and mRNA expression of mitochondrial biogenesis markers were assessed by real-time polymerase chain reaction and expression of insulin receptor substrate (IRS)-1 and Akt were examined by Western blot analysis in skeletal muscle. In C2C12 cells, insulin sensitivity was measured by 2-deoxyglucose uptake and Western blot analysis was used to examine the expression of IRS-1 and Akt. RESULTS: SIN-1 improved insulin sensitivity in C2C12 cells and skeletal muscles of SD rats. In addition, SIN-1 decreased triglyceride content and increased fatty acid oxidation in skeletal muscle. Mitochondrial DNA contents and biogenesis in the skeletal muscle were increased by SIN-1 treatment. Moreover, SIN-1 increased the expression of phosphor-IRS-1 and phosphor-Akt in the skeletal muscle and muscle cells. CONCLUSION: Our results suggest that NO mediates glucose uptake in skeletal muscle both in vitro and in vivo by improving mitochondrial function and stimulating insulin signaling pathways.
